Pharmacy and healthcare retail group Dis-Chem says it is trading at pre-Covid levels in South Africa, with expansions and acquisitions boosting its reach and driving profitability.
In its interim results for the six-month period ending 31 August 2022, Dis-Chem reported group revenue growth of 9.3% to R16.3 billion over the corresponding half-year period.
“With consumer shopping habits and routines just about restored to pre-Covid levels, we have experienced a normalisation in our operating environment for the first time in over two years,” said Dis-Chem chief executive officer, Ivan Saltzman. “Work has commenced on replicating our leading pharmacy market share in Gauteng, across other provinces. In this regard, we continue to innovate to realise our vision of integrated primary healthcare, aimed at increasing access, reducing cost and delivering better health outcomes for more South Africans,” he said.
When excluding wholesale revenue to Medicare stores in the prior period , external revenue grew by 20.4%, comprising independent pharmacy growth of 15.8% and TLC growth of 22.5%. Retail total income grew by 19.1%, with the retail margin increasing from 27.7% to 30.2% over the comparable period.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Dis-Chem ups dividend, remains mum on letterIn its interim results, the pharmacy chain made no mention of a letter from its CEO placing a moratorium on employing white people
Read more »
South Africans are paying R7,000 for what looks awfully like R1,500 medical boots | BusinessinsiderSouth Africans are buying shoes that look remarkably like orthopaedic boots, but with a price tag of R7,000 rather than the R3,000 they could pay for the medical version – which is sold individually, because most people only need one at a time.
Read more »
South Africans are paying R7,000 for what looks awfully like R1,500 medical boots | BusinessinsiderSouth Africans are buying shoes that look remarkably like orthopaedic boots, but with a price tag of R7,000 rather than the R3,000 they could pay for the medical version – which is sold individually, because most people only need one at a time.
Read more »
Dis-Chem ups dividend, remains mum on letterIn its interim results, the pharmacy chain made no mention of a letter from its CEO placing a moratorium on employing white people
Read more »
Covid-19 spikes in four provincesThe health department is warning of a spike in Covid-19 cases in four provinces.
Read more »
COVID-19: EU regulator recommends adding heavy periods to side effects of mRNA Covid-19 shotsOct 28 (Reuters) - A European Medicines Agency (EMA) committee on Friday recommended adding heavy menstrual bleeding to the list of side effect of mRNA Covid-19 vaccines made by Moderna MRNA.O, as well as Pfizer PFE.N and its partner BioNTech 22UAy.DE.
Read more »